• Northern Delegation Showcases Excellence to US Audience
    l:r Catherine Gresty Events Associate NHSA, Professor Ian Greer University of Manchester & Chair NHSA, Hannah Davies, Head of External Affairs NHSA, Dr Hakim Yadi OBE CEO NHSA and Suzanne Ali-Hassan Head of Corporate Engagement NHSA

News & Views

Northern Delegation Showcases Excellence to US Audience

Jun 24 2018

During the BIO 2018 International Convention held in Boston, USA a 14-strong Northern Powerhouse delegation, brought together by the UK’s Northern Health Science Alliance (NHSA), showcased the region’s excellence in Anti- Microbial Resistance (AMR) health research and clinical trials while celebrating 70 years of the NHS to an audience of global industry and scientists at BIO 2018 International Convention in Boston.

Health science is £17.5 billion of the North of England’s £304bn output and is forecast to grow by 44.6% by 2030. Around 570,000 people are employed in health sciences across the North – 7.5% of the region’s workforce. The NHSA also represents eight universities, eight teaching hospitals and four academic health science networks across the region.

An international audience heard about the work of experts from the AMR Centre in Alderley Park, the Centre of Excellence in Infectious Diseases Research in Liverpool, the National Institute for Health and Care Excellence and leading academics from the University of Manchester and York, at a Breakfast event on June 4th and at a seminar on June 6th.

Speaking at the AMR seminar Professor Ian Greer, Vice President of the University of Manchester chair of the Northern Health Science Alliance said: “The North of England has the largest cluster of companies working in antimicrobial resistance in the country.

“We’ve got great opportunities for international industry to come into the North of England and to work with researchers, SMEs and the NHS to look at not only AMR but areas such as digital health, cancer, ageing and personalised medicine.

“To be selected for a seminar at BIO International Convention, the biggest of its kind in the world, is a great honour and reflects the excellent work the North is doing.”

At the event, Dr Hakim Yadi CEO of the NHSA said: “We are delivering the strongest North of England programme ever to BIO International Convention – showcasing the opportunities available in health innovation to global leaders in industry. It’s time the North’s capabilities in health science – and the opportunities is offers for global industry – are showcased to the world, building new trading partnerships to benefit the health and wealth of not only the North but the whole UK.


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

FORUMESURE

Apr 22 2024 Marrakech, Morroco

Korea Lab 2024

Apr 23 2024 Kintex, South Korea

Korea Chem 2024

Apr 23 2024 Seoul, South Korea

Lab Indonesia

Apr 24 2024 Jakarta, Indonesia

View all events